Global Levoamlodipine Supply, Demand and Key Producers, 2023-2029
The global Levoamlodipine market size is expected to reach $ 75160 million by 2029, rising at a market growth of 10.8% CAGR during the forecast period (2023-2029).
Hypertension is a common cardiovascular disease affecting a large proportion of the global population. The increasing prevalence of hypertension worldwide is driving the demand for effective antihypertensive drugs such as S-amlodipine.
Levoamlodipine can effectively control 24-hour blood pressure, especially at night blood pressure control has unique advantages, it can also effectively prevent the sudden rise of blood pressure in the morning, reduce the sharp rise and fall of blood pressure, so as to effectively maintain the blood flow of important organs and protect the function of target organs.
This report studies the global Levoamlodipine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Levoamlodipine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Levoamlodipine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Levoamlodipine total production and demand, 2018-2029, (K Units)
Global Levoamlodipine total production value, 2018-2029, (USD Million)
Global Levoamlodipine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Levoamlodipine consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Levoamlodipine domestic production, consumption, key domestic manufacturers and share
Global Levoamlodipine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Levoamlodipine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Levoamlodipine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Levoamlodipine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Aristo Pharmaceuticals Pvt Ltd, Novartis, Pfizer, Lek, TEVA, Macleods Pharmaceuticals, Caraco Pharmaceutical, Sanis Health and Jamp Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Levoamlodipine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Levoamlodipine Market, By Region:
1. How big is the global Levoamlodipine market?
2. What is the demand of the global Levoamlodipine market?
3. What is the year over year growth of the global Levoamlodipine market?
4. What is the production and production value of the global Levoamlodipine market?
5. Who are the key producers in the global Levoamlodipine market?
6. What are the growth factors driving the market demand?
Hypertension is a common cardiovascular disease affecting a large proportion of the global population. The increasing prevalence of hypertension worldwide is driving the demand for effective antihypertensive drugs such as S-amlodipine.
Levoamlodipine can effectively control 24-hour blood pressure, especially at night blood pressure control has unique advantages, it can also effectively prevent the sudden rise of blood pressure in the morning, reduce the sharp rise and fall of blood pressure, so as to effectively maintain the blood flow of important organs and protect the function of target organs.
This report studies the global Levoamlodipine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Levoamlodipine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Levoamlodipine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Levoamlodipine total production and demand, 2018-2029, (K Units)
Global Levoamlodipine total production value, 2018-2029, (USD Million)
Global Levoamlodipine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Levoamlodipine consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Levoamlodipine domestic production, consumption, key domestic manufacturers and share
Global Levoamlodipine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Levoamlodipine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Levoamlodipine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Levoamlodipine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Aristo Pharmaceuticals Pvt Ltd, Novartis, Pfizer, Lek, TEVA, Macleods Pharmaceuticals, Caraco Pharmaceutical, Sanis Health and Jamp Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Levoamlodipine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Levoamlodipine Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Amlodipine Besylate Tablets
- Amlodipine Mesylate Tablets
- Amlodipine Maleate Tablets
- Hypertension
- Angina pectoris
- Aristo Pharmaceuticals Pvt Ltd
- Novartis
- Pfizer
- Lek
- TEVA
- Macleods Pharmaceuticals
- Caraco Pharmaceutical
- Sanis Health
- Jamp Pharma
- Accel Pharma
- Jubilant Generics
- Angita Pharma
- Florida DOH Central Pharmacy
- Chengdu Di'ao Pharmaceutical Group Co., Ltd.
- Yangzijiang Pharmaceutical
1. How big is the global Levoamlodipine market?
2. What is the demand of the global Levoamlodipine market?
3. What is the year over year growth of the global Levoamlodipine market?
4. What is the production and production value of the global Levoamlodipine market?
5. Who are the key producers in the global Levoamlodipine market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Levoamlodipine Introduction
1.2 World Levoamlodipine Supply & Forecast
1.2.1 World Levoamlodipine Production Value (2018 & 2022 & 2029)
1.2.2 World Levoamlodipine Production (2018-2029)
1.2.3 World Levoamlodipine Pricing Trends (2018-2029)
1.3 World Levoamlodipine Production by Region (Based on Production Site)
1.3.1 World Levoamlodipine Production Value by Region (2018-2029)
1.3.2 World Levoamlodipine Production by Region (2018-2029)
1.3.3 World Levoamlodipine Average Price by Region (2018-2029)
1.3.4 North America Levoamlodipine Production (2018-2029)
1.3.5 Europe Levoamlodipine Production (2018-2029)
1.3.6 China Levoamlodipine Production (2018-2029)
1.3.7 Japan Levoamlodipine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Levoamlodipine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Levoamlodipine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Levoamlodipine Demand (2018-2029)
2.2 World Levoamlodipine Consumption by Region
2.2.1 World Levoamlodipine Consumption by Region (2018-2023)
2.2.2 World Levoamlodipine Consumption Forecast by Region (2024-2029)
2.3 United States Levoamlodipine Consumption (2018-2029)
2.4 China Levoamlodipine Consumption (2018-2029)
2.5 Europe Levoamlodipine Consumption (2018-2029)
2.6 Japan Levoamlodipine Consumption (2018-2029)
2.7 South Korea Levoamlodipine Consumption (2018-2029)
2.8 ASEAN Levoamlodipine Consumption (2018-2029)
2.9 India Levoamlodipine Consumption (2018-2029)
3 WORLD LEVOAMLODIPINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Levoamlodipine Production Value by Manufacturer (2018-2023)
3.2 World Levoamlodipine Production by Manufacturer (2018-2023)
3.3 World Levoamlodipine Average Price by Manufacturer (2018-2023)
3.4 Levoamlodipine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Levoamlodipine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Levoamlodipine in 2022
3.5.3 Global Concentration Ratios (CR8) for Levoamlodipine in 2022
3.6 Levoamlodipine Market: Overall Company Footprint Analysis
3.6.1 Levoamlodipine Market: Region Footprint
3.6.2 Levoamlodipine Market: Company Product Type Footprint
3.6.3 Levoamlodipine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Levoamlodipine Production Value Comparison
4.1.1 United States VS China: Levoamlodipine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Levoamlodipine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Levoamlodipine Production Comparison
4.2.1 United States VS China: Levoamlodipine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Levoamlodipine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Levoamlodipine Consumption Comparison
4.3.1 United States VS China: Levoamlodipine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Levoamlodipine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Levoamlodipine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Levoamlodipine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Levoamlodipine Production Value (2018-2023)
4.4.3 United States Based Manufacturers Levoamlodipine Production (2018-2023)
4.5 China Based Levoamlodipine Manufacturers and Market Share
4.5.1 China Based Levoamlodipine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Levoamlodipine Production Value (2018-2023)
4.5.3 China Based Manufacturers Levoamlodipine Production (2018-2023)
4.6 Rest of World Based Levoamlodipine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Levoamlodipine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Levoamlodipine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Levoamlodipine Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Levoamlodipine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Amlodipine Besylate Tablets
5.2.2 Amlodipine Mesylate Tablets
5.2.3 Amlodipine Maleate Tablets
5.3 Market Segment by Type
5.3.1 World Levoamlodipine Production by Type (2018-2029)
5.3.2 World Levoamlodipine Production Value by Type (2018-2029)
5.3.3 World Levoamlodipine Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Levoamlodipine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hypertension
6.2.2 Angina pectoris
6.3 Market Segment by Application
6.3.1 World Levoamlodipine Production by Application (2018-2029)
6.3.2 World Levoamlodipine Production Value by Application (2018-2029)
6.3.3 World Levoamlodipine Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Aristo Pharmaceuticals Pvt Ltd
7.1.1 Aristo Pharmaceuticals Pvt Ltd Details
7.1.2 Aristo Pharmaceuticals Pvt Ltd Major Business
7.1.3 Aristo Pharmaceuticals Pvt Ltd Levoamlodipine Product and Services
7.1.4 Aristo Pharmaceuticals Pvt Ltd Levoamlodipine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Aristo Pharmaceuticals Pvt Ltd Recent Developments/Updates
7.1.6 Aristo Pharmaceuticals Pvt Ltd Competitive Strengths & Weaknesses
7.2 Novartis
7.2.1 Novartis Details
7.2.2 Novartis Major Business
7.2.3 Novartis Levoamlodipine Product and Services
7.2.4 Novartis Levoamlodipine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Novartis Recent Developments/Updates
7.2.6 Novartis Competitive Strengths & Weaknesses
7.3 Pfizer
7.3.1 Pfizer Details
7.3.2 Pfizer Major Business
7.3.3 Pfizer Levoamlodipine Product and Services
7.3.4 Pfizer Levoamlodipine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Pfizer Recent Developments/Updates
7.3.6 Pfizer Competitive Strengths & Weaknesses
7.4 Lek
7.4.1 Lek Details
7.4.2 Lek Major Business
7.4.3 Lek Levoamlodipine Product and Services
7.4.4 Lek Levoamlodipine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Lek Recent Developments/Updates
7.4.6 Lek Competitive Strengths & Weaknesses
7.5 TEVA
7.5.1 TEVA Details
7.5.2 TEVA Major Business
7.5.3 TEVA Levoamlodipine Product and Services
7.5.4 TEVA Levoamlodipine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 TEVA Recent Developments/Updates
7.5.6 TEVA Competitive Strengths & Weaknesses
7.6 Macleods Pharmaceuticals
7.6.1 Macleods Pharmaceuticals Details
7.6.2 Macleods Pharmaceuticals Major Business
7.6.3 Macleods Pharmaceuticals Levoamlodipine Product and Services
7.6.4 Macleods Pharmaceuticals Levoamlodipine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Macleods Pharmaceuticals Recent Developments/Updates
7.6.6 Macleods Pharmaceuticals Competitive Strengths & Weaknesses
7.7 Caraco Pharmaceutical
7.7.1 Caraco Pharmaceutical Details
7.7.2 Caraco Pharmaceutical Major Business
7.7.3 Caraco Pharmaceutical Levoamlodipine Product and Services
7.7.4 Caraco Pharmaceutical Levoamlodipine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Caraco Pharmaceutical Recent Developments/Updates
7.7.6 Caraco Pharmaceutical Competitive Strengths & Weaknesses
7.8 Sanis Health
7.8.1 Sanis Health Details
7.8.2 Sanis Health Major Business
7.8.3 Sanis Health Levoamlodipine Product and Services
7.8.4 Sanis Health Levoamlodipine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Sanis Health Recent Developments/Updates
7.8.6 Sanis Health Competitive Strengths & Weaknesses
7.9 Jamp Pharma
7.9.1 Jamp Pharma Details
7.9.2 Jamp Pharma Major Business
7.9.3 Jamp Pharma Levoamlodipine Product and Services
7.9.4 Jamp Pharma Levoamlodipine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Jamp Pharma Recent Developments/Updates
7.9.6 Jamp Pharma Competitive Strengths & Weaknesses
7.10 Accel Pharma
7.10.1 Accel Pharma Details
7.10.2 Accel Pharma Major Business
7.10.3 Accel Pharma Levoamlodipine Product and Services
7.10.4 Accel Pharma Levoamlodipine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Accel Pharma Recent Developments/Updates
7.10.6 Accel Pharma Competitive Strengths & Weaknesses
7.11 Jubilant Generics
7.11.1 Jubilant Generics Details
7.11.2 Jubilant Generics Major Business
7.11.3 Jubilant Generics Levoamlodipine Product and Services
7.11.4 Jubilant Generics Levoamlodipine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Jubilant Generics Recent Developments/Updates
7.11.6 Jubilant Generics Competitive Strengths & Weaknesses
7.12 Angita Pharma
7.12.1 Angita Pharma Details
7.12.2 Angita Pharma Major Business
7.12.3 Angita Pharma Levoamlodipine Product and Services
7.12.4 Angita Pharma Levoamlodipine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Angita Pharma Recent Developments/Updates
7.12.6 Angita Pharma Competitive Strengths & Weaknesses
7.13 Florida DOH Central Pharmacy
7.13.1 Florida DOH Central Pharmacy Details
7.13.2 Florida DOH Central Pharmacy Major Business
7.13.3 Florida DOH Central Pharmacy Levoamlodipine Product and Services
7.13.4 Florida DOH Central Pharmacy Levoamlodipine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Florida DOH Central Pharmacy Recent Developments/Updates
7.13.6 Florida DOH Central Pharmacy Competitive Strengths & Weaknesses
7.14 Chengdu Di'ao Pharmaceutical Group Co., Ltd.
7.14.1 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Details
7.14.2 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Major Business
7.14.3 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Levoamlodipine Product and Services
7.14.4 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Levoamlodipine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Recent Developments/Updates
7.14.6 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Competitive Strengths & Weaknesses
7.15 Yangzijiang Pharmaceutical
7.15.1 Yangzijiang Pharmaceutical Details
7.15.2 Yangzijiang Pharmaceutical Major Business
7.15.3 Yangzijiang Pharmaceutical Levoamlodipine Product and Services
7.15.4 Yangzijiang Pharmaceutical Levoamlodipine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Yangzijiang Pharmaceutical Recent Developments/Updates
7.15.6 Yangzijiang Pharmaceutical Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Levoamlodipine Industry Chain
8.2 Levoamlodipine Upstream Analysis
8.2.1 Levoamlodipine Core Raw Materials
8.2.2 Main Manufacturers of Levoamlodipine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Levoamlodipine Production Mode
8.6 Levoamlodipine Procurement Model
8.7 Levoamlodipine Industry Sales Model and Sales Channels
8.7.1 Levoamlodipine Sales Model
8.7.2 Levoamlodipine Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Levoamlodipine Introduction
1.2 World Levoamlodipine Supply & Forecast
1.2.1 World Levoamlodipine Production Value (2018 & 2022 & 2029)
1.2.2 World Levoamlodipine Production (2018-2029)
1.2.3 World Levoamlodipine Pricing Trends (2018-2029)
1.3 World Levoamlodipine Production by Region (Based on Production Site)
1.3.1 World Levoamlodipine Production Value by Region (2018-2029)
1.3.2 World Levoamlodipine Production by Region (2018-2029)
1.3.3 World Levoamlodipine Average Price by Region (2018-2029)
1.3.4 North America Levoamlodipine Production (2018-2029)
1.3.5 Europe Levoamlodipine Production (2018-2029)
1.3.6 China Levoamlodipine Production (2018-2029)
1.3.7 Japan Levoamlodipine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Levoamlodipine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Levoamlodipine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Levoamlodipine Demand (2018-2029)
2.2 World Levoamlodipine Consumption by Region
2.2.1 World Levoamlodipine Consumption by Region (2018-2023)
2.2.2 World Levoamlodipine Consumption Forecast by Region (2024-2029)
2.3 United States Levoamlodipine Consumption (2018-2029)
2.4 China Levoamlodipine Consumption (2018-2029)
2.5 Europe Levoamlodipine Consumption (2018-2029)
2.6 Japan Levoamlodipine Consumption (2018-2029)
2.7 South Korea Levoamlodipine Consumption (2018-2029)
2.8 ASEAN Levoamlodipine Consumption (2018-2029)
2.9 India Levoamlodipine Consumption (2018-2029)
3 WORLD LEVOAMLODIPINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Levoamlodipine Production Value by Manufacturer (2018-2023)
3.2 World Levoamlodipine Production by Manufacturer (2018-2023)
3.3 World Levoamlodipine Average Price by Manufacturer (2018-2023)
3.4 Levoamlodipine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Levoamlodipine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Levoamlodipine in 2022
3.5.3 Global Concentration Ratios (CR8) for Levoamlodipine in 2022
3.6 Levoamlodipine Market: Overall Company Footprint Analysis
3.6.1 Levoamlodipine Market: Region Footprint
3.6.2 Levoamlodipine Market: Company Product Type Footprint
3.6.3 Levoamlodipine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Levoamlodipine Production Value Comparison
4.1.1 United States VS China: Levoamlodipine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Levoamlodipine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Levoamlodipine Production Comparison
4.2.1 United States VS China: Levoamlodipine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Levoamlodipine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Levoamlodipine Consumption Comparison
4.3.1 United States VS China: Levoamlodipine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Levoamlodipine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Levoamlodipine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Levoamlodipine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Levoamlodipine Production Value (2018-2023)
4.4.3 United States Based Manufacturers Levoamlodipine Production (2018-2023)
4.5 China Based Levoamlodipine Manufacturers and Market Share
4.5.1 China Based Levoamlodipine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Levoamlodipine Production Value (2018-2023)
4.5.3 China Based Manufacturers Levoamlodipine Production (2018-2023)
4.6 Rest of World Based Levoamlodipine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Levoamlodipine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Levoamlodipine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Levoamlodipine Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Levoamlodipine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Amlodipine Besylate Tablets
5.2.2 Amlodipine Mesylate Tablets
5.2.3 Amlodipine Maleate Tablets
5.3 Market Segment by Type
5.3.1 World Levoamlodipine Production by Type (2018-2029)
5.3.2 World Levoamlodipine Production Value by Type (2018-2029)
5.3.3 World Levoamlodipine Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Levoamlodipine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hypertension
6.2.2 Angina pectoris
6.3 Market Segment by Application
6.3.1 World Levoamlodipine Production by Application (2018-2029)
6.3.2 World Levoamlodipine Production Value by Application (2018-2029)
6.3.3 World Levoamlodipine Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Aristo Pharmaceuticals Pvt Ltd
7.1.1 Aristo Pharmaceuticals Pvt Ltd Details
7.1.2 Aristo Pharmaceuticals Pvt Ltd Major Business
7.1.3 Aristo Pharmaceuticals Pvt Ltd Levoamlodipine Product and Services
7.1.4 Aristo Pharmaceuticals Pvt Ltd Levoamlodipine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Aristo Pharmaceuticals Pvt Ltd Recent Developments/Updates
7.1.6 Aristo Pharmaceuticals Pvt Ltd Competitive Strengths & Weaknesses
7.2 Novartis
7.2.1 Novartis Details
7.2.2 Novartis Major Business
7.2.3 Novartis Levoamlodipine Product and Services
7.2.4 Novartis Levoamlodipine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Novartis Recent Developments/Updates
7.2.6 Novartis Competitive Strengths & Weaknesses
7.3 Pfizer
7.3.1 Pfizer Details
7.3.2 Pfizer Major Business
7.3.3 Pfizer Levoamlodipine Product and Services
7.3.4 Pfizer Levoamlodipine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Pfizer Recent Developments/Updates
7.3.6 Pfizer Competitive Strengths & Weaknesses
7.4 Lek
7.4.1 Lek Details
7.4.2 Lek Major Business
7.4.3 Lek Levoamlodipine Product and Services
7.4.4 Lek Levoamlodipine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Lek Recent Developments/Updates
7.4.6 Lek Competitive Strengths & Weaknesses
7.5 TEVA
7.5.1 TEVA Details
7.5.2 TEVA Major Business
7.5.3 TEVA Levoamlodipine Product and Services
7.5.4 TEVA Levoamlodipine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 TEVA Recent Developments/Updates
7.5.6 TEVA Competitive Strengths & Weaknesses
7.6 Macleods Pharmaceuticals
7.6.1 Macleods Pharmaceuticals Details
7.6.2 Macleods Pharmaceuticals Major Business
7.6.3 Macleods Pharmaceuticals Levoamlodipine Product and Services
7.6.4 Macleods Pharmaceuticals Levoamlodipine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Macleods Pharmaceuticals Recent Developments/Updates
7.6.6 Macleods Pharmaceuticals Competitive Strengths & Weaknesses
7.7 Caraco Pharmaceutical
7.7.1 Caraco Pharmaceutical Details
7.7.2 Caraco Pharmaceutical Major Business
7.7.3 Caraco Pharmaceutical Levoamlodipine Product and Services
7.7.4 Caraco Pharmaceutical Levoamlodipine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Caraco Pharmaceutical Recent Developments/Updates
7.7.6 Caraco Pharmaceutical Competitive Strengths & Weaknesses
7.8 Sanis Health
7.8.1 Sanis Health Details
7.8.2 Sanis Health Major Business
7.8.3 Sanis Health Levoamlodipine Product and Services
7.8.4 Sanis Health Levoamlodipine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Sanis Health Recent Developments/Updates
7.8.6 Sanis Health Competitive Strengths & Weaknesses
7.9 Jamp Pharma
7.9.1 Jamp Pharma Details
7.9.2 Jamp Pharma Major Business
7.9.3 Jamp Pharma Levoamlodipine Product and Services
7.9.4 Jamp Pharma Levoamlodipine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Jamp Pharma Recent Developments/Updates
7.9.6 Jamp Pharma Competitive Strengths & Weaknesses
7.10 Accel Pharma
7.10.1 Accel Pharma Details
7.10.2 Accel Pharma Major Business
7.10.3 Accel Pharma Levoamlodipine Product and Services
7.10.4 Accel Pharma Levoamlodipine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Accel Pharma Recent Developments/Updates
7.10.6 Accel Pharma Competitive Strengths & Weaknesses
7.11 Jubilant Generics
7.11.1 Jubilant Generics Details
7.11.2 Jubilant Generics Major Business
7.11.3 Jubilant Generics Levoamlodipine Product and Services
7.11.4 Jubilant Generics Levoamlodipine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Jubilant Generics Recent Developments/Updates
7.11.6 Jubilant Generics Competitive Strengths & Weaknesses
7.12 Angita Pharma
7.12.1 Angita Pharma Details
7.12.2 Angita Pharma Major Business
7.12.3 Angita Pharma Levoamlodipine Product and Services
7.12.4 Angita Pharma Levoamlodipine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Angita Pharma Recent Developments/Updates
7.12.6 Angita Pharma Competitive Strengths & Weaknesses
7.13 Florida DOH Central Pharmacy
7.13.1 Florida DOH Central Pharmacy Details
7.13.2 Florida DOH Central Pharmacy Major Business
7.13.3 Florida DOH Central Pharmacy Levoamlodipine Product and Services
7.13.4 Florida DOH Central Pharmacy Levoamlodipine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Florida DOH Central Pharmacy Recent Developments/Updates
7.13.6 Florida DOH Central Pharmacy Competitive Strengths & Weaknesses
7.14 Chengdu Di'ao Pharmaceutical Group Co., Ltd.
7.14.1 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Details
7.14.2 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Major Business
7.14.3 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Levoamlodipine Product and Services
7.14.4 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Levoamlodipine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Recent Developments/Updates
7.14.6 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Competitive Strengths & Weaknesses
7.15 Yangzijiang Pharmaceutical
7.15.1 Yangzijiang Pharmaceutical Details
7.15.2 Yangzijiang Pharmaceutical Major Business
7.15.3 Yangzijiang Pharmaceutical Levoamlodipine Product and Services
7.15.4 Yangzijiang Pharmaceutical Levoamlodipine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Yangzijiang Pharmaceutical Recent Developments/Updates
7.15.6 Yangzijiang Pharmaceutical Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Levoamlodipine Industry Chain
8.2 Levoamlodipine Upstream Analysis
8.2.1 Levoamlodipine Core Raw Materials
8.2.2 Main Manufacturers of Levoamlodipine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Levoamlodipine Production Mode
8.6 Levoamlodipine Procurement Model
8.7 Levoamlodipine Industry Sales Model and Sales Channels
8.7.1 Levoamlodipine Sales Model
8.7.2 Levoamlodipine Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Levoamlodipine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Levoamlodipine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Levoamlodipine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Levoamlodipine Production Value Market Share by Region (2018-2023)
Table 5. World Levoamlodipine Production Value Market Share by Region (2024-2029)
Table 6. World Levoamlodipine Production by Region (2018-2023) & (K Units)
Table 7. World Levoamlodipine Production by Region (2024-2029) & (K Units)
Table 8. World Levoamlodipine Production Market Share by Region (2018-2023)
Table 9. World Levoamlodipine Production Market Share by Region (2024-2029)
Table 10. World Levoamlodipine Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Levoamlodipine Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Levoamlodipine Major Market Trends
Table 13. World Levoamlodipine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Levoamlodipine Consumption by Region (2018-2023) & (K Units)
Table 15. World Levoamlodipine Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Levoamlodipine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Levoamlodipine Producers in 2022
Table 18. World Levoamlodipine Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Levoamlodipine Producers in 2022
Table 20. World Levoamlodipine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Levoamlodipine Company Evaluation Quadrant
Table 22. World Levoamlodipine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Levoamlodipine Production Site of Key Manufacturer
Table 24. Levoamlodipine Market: Company Product Type Footprint
Table 25. Levoamlodipine Market: Company Product Application Footprint
Table 26. Levoamlodipine Competitive Factors
Table 27. Levoamlodipine New Entrant and Capacity Expansion Plans
Table 28. Levoamlodipine Mergers & Acquisitions Activity
Table 29. United States VS China Levoamlodipine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Levoamlodipine Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Levoamlodipine Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Levoamlodipine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Levoamlodipine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Levoamlodipine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Levoamlodipine Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Levoamlodipine Production Market Share (2018-2023)
Table 37. China Based Levoamlodipine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Levoamlodipine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Levoamlodipine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Levoamlodipine Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Levoamlodipine Production Market Share (2018-2023)
Table 42. Rest of World Based Levoamlodipine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Levoamlodipine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Levoamlodipine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Levoamlodipine Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Levoamlodipine Production Market Share (2018-2023)
Table 47. World Levoamlodipine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Levoamlodipine Production by Type (2018-2023) & (K Units)
Table 49. World Levoamlodipine Production by Type (2024-2029) & (K Units)
Table 50. World Levoamlodipine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Levoamlodipine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Levoamlodipine Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Levoamlodipine Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Levoamlodipine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Levoamlodipine Production by Application (2018-2023) & (K Units)
Table 56. World Levoamlodipine Production by Application (2024-2029) & (K Units)
Table 57. World Levoamlodipine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Levoamlodipine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Levoamlodipine Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Levoamlodipine Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Aristo Pharmaceuticals Pvt Ltd Basic Information, Manufacturing Base and Competitors
Table 62. Aristo Pharmaceuticals Pvt Ltd Major Business
Table 63. Aristo Pharmaceuticals Pvt Ltd Levoamlodipine Product and Services
Table 64. Aristo Pharmaceuticals Pvt Ltd Levoamlodipine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Aristo Pharmaceuticals Pvt Ltd Recent Developments/Updates
Table 66. Aristo Pharmaceuticals Pvt Ltd Competitive Strengths & Weaknesses
Table 67. Novartis Basic Information, Manufacturing Base and Competitors
Table 68. Novartis Major Business
Table 69. Novartis Levoamlodipine Product and Services
Table 70. Novartis Levoamlodipine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Novartis Recent Developments/Updates
Table 72. Novartis Competitive Strengths & Weaknesses
Table 73. Pfizer Basic Information, Manufacturing Base and Competitors
Table 74. Pfizer Major Business
Table 75. Pfizer Levoamlodipine Product and Services
Table 76. Pfizer Levoamlodipine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Pfizer Recent Developments/Updates
Table 78. Pfizer Competitive Strengths & Weaknesses
Table 79. Lek Basic Information, Manufacturing Base and Competitors
Table 80. Lek Major Business
Table 81. Lek Levoamlodipine Product and Services
Table 82. Lek Levoamlodipine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Lek Recent Developments/Updates
Table 84. Lek Competitive Strengths & Weaknesses
Table 85. TEVA Basic Information, Manufacturing Base and Competitors
Table 86. TEVA Major Business
Table 87. TEVA Levoamlodipine Product and Services
Table 88. TEVA Levoamlodipine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. TEVA Recent Developments/Updates
Table 90. TEVA Competitive Strengths & Weaknesses
Table 91. Macleods Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 92. Macleods Pharmaceuticals Major Business
Table 93. Macleods Pharmaceuticals Levoamlodipine Product and Services
Table 94. Macleods Pharmaceuticals Levoamlodipine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Macleods Pharmaceuticals Recent Developments/Updates
Table 96. Macleods Pharmaceuticals Competitive Strengths & Weaknesses
Table 97. Caraco Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 98. Caraco Pharmaceutical Major Business
Table 99. Caraco Pharmaceutical Levoamlodipine Product and Services
Table 100. Caraco Pharmaceutical Levoamlodipine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Caraco Pharmaceutical Recent Developments/Updates
Table 102. Caraco Pharmaceutical Competitive Strengths & Weaknesses
Table 103. Sanis Health Basic Information, Manufacturing Base and Competitors
Table 104. Sanis Health Major Business
Table 105. Sanis Health Levoamlodipine Product and Services
Table 106. Sanis Health Levoamlodipine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Sanis Health Recent Developments/Updates
Table 108. Sanis Health Competitive Strengths & Weaknesses
Table 109. Jamp Pharma Basic Information, Manufacturing Base and Competitors
Table 110. Jamp Pharma Major Business
Table 111. Jamp Pharma Levoamlodipine Product and Services
Table 112. Jamp Pharma Levoamlodipine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Jamp Pharma Recent Developments/Updates
Table 114. Jamp Pharma Competitive Strengths & Weaknesses
Table 115. Accel Pharma Basic Information, Manufacturing Base and Competitors
Table 116. Accel Pharma Major Business
Table 117. Accel Pharma Levoamlodipine Product and Services
Table 118. Accel Pharma Levoamlodipine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Accel Pharma Recent Developments/Updates
Table 120. Accel Pharma Competitive Strengths & Weaknesses
Table 121. Jubilant Generics Basic Information, Manufacturing Base and Competitors
Table 122. Jubilant Generics Major Business
Table 123. Jubilant Generics Levoamlodipine Product and Services
Table 124. Jubilant Generics Levoamlodipine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Jubilant Generics Recent Developments/Updates
Table 126. Jubilant Generics Competitive Strengths & Weaknesses
Table 127. Angita Pharma Basic Information, Manufacturing Base and Competitors
Table 128. Angita Pharma Major Business
Table 129. Angita Pharma Levoamlodipine Product and Services
Table 130. Angita Pharma Levoamlodipine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Angita Pharma Recent Developments/Updates
Table 132. Angita Pharma Competitive Strengths & Weaknesses
Table 133. Florida DOH Central Pharmacy Basic Information, Manufacturing Base and Competitors
Table 134. Florida DOH Central Pharmacy Major Business
Table 135. Florida DOH Central Pharmacy Levoamlodipine Product and Services
Table 136. Florida DOH Central Pharmacy Levoamlodipine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Florida DOH Central Pharmacy Recent Developments/Updates
Table 138. Florida DOH Central Pharmacy Competitive Strengths & Weaknesses
Table 139. Chengdu Di'ao Pharmaceutical Group Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 140. Chengdu Di'ao Pharmaceutical Group Co., Ltd. Major Business
Table 141. Chengdu Di'ao Pharmaceutical Group Co., Ltd. Levoamlodipine Product and Services
Table 142. Chengdu Di'ao Pharmaceutical Group Co., Ltd. Levoamlodipine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Chengdu Di'ao Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 144. Yangzijiang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 145. Yangzijiang Pharmaceutical Major Business
Table 146. Yangzijiang Pharmaceutical Levoamlodipine Product and Services
Table 147. Yangzijiang Pharmaceutical Levoamlodipine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 148. Global Key Players of Levoamlodipine Upstream (Raw Materials)
Table 149. Levoamlodipine Typical Customers
Table 150. Levoamlodipine Typical Distributors
Table 1. World Levoamlodipine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Levoamlodipine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Levoamlodipine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Levoamlodipine Production Value Market Share by Region (2018-2023)
Table 5. World Levoamlodipine Production Value Market Share by Region (2024-2029)
Table 6. World Levoamlodipine Production by Region (2018-2023) & (K Units)
Table 7. World Levoamlodipine Production by Region (2024-2029) & (K Units)
Table 8. World Levoamlodipine Production Market Share by Region (2018-2023)
Table 9. World Levoamlodipine Production Market Share by Region (2024-2029)
Table 10. World Levoamlodipine Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Levoamlodipine Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Levoamlodipine Major Market Trends
Table 13. World Levoamlodipine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Levoamlodipine Consumption by Region (2018-2023) & (K Units)
Table 15. World Levoamlodipine Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Levoamlodipine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Levoamlodipine Producers in 2022
Table 18. World Levoamlodipine Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Levoamlodipine Producers in 2022
Table 20. World Levoamlodipine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Levoamlodipine Company Evaluation Quadrant
Table 22. World Levoamlodipine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Levoamlodipine Production Site of Key Manufacturer
Table 24. Levoamlodipine Market: Company Product Type Footprint
Table 25. Levoamlodipine Market: Company Product Application Footprint
Table 26. Levoamlodipine Competitive Factors
Table 27. Levoamlodipine New Entrant and Capacity Expansion Plans
Table 28. Levoamlodipine Mergers & Acquisitions Activity
Table 29. United States VS China Levoamlodipine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Levoamlodipine Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Levoamlodipine Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Levoamlodipine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Levoamlodipine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Levoamlodipine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Levoamlodipine Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Levoamlodipine Production Market Share (2018-2023)
Table 37. China Based Levoamlodipine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Levoamlodipine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Levoamlodipine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Levoamlodipine Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Levoamlodipine Production Market Share (2018-2023)
Table 42. Rest of World Based Levoamlodipine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Levoamlodipine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Levoamlodipine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Levoamlodipine Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Levoamlodipine Production Market Share (2018-2023)
Table 47. World Levoamlodipine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Levoamlodipine Production by Type (2018-2023) & (K Units)
Table 49. World Levoamlodipine Production by Type (2024-2029) & (K Units)
Table 50. World Levoamlodipine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Levoamlodipine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Levoamlodipine Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Levoamlodipine Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Levoamlodipine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Levoamlodipine Production by Application (2018-2023) & (K Units)
Table 56. World Levoamlodipine Production by Application (2024-2029) & (K Units)
Table 57. World Levoamlodipine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Levoamlodipine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Levoamlodipine Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Levoamlodipine Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Aristo Pharmaceuticals Pvt Ltd Basic Information, Manufacturing Base and Competitors
Table 62. Aristo Pharmaceuticals Pvt Ltd Major Business
Table 63. Aristo Pharmaceuticals Pvt Ltd Levoamlodipine Product and Services
Table 64. Aristo Pharmaceuticals Pvt Ltd Levoamlodipine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Aristo Pharmaceuticals Pvt Ltd Recent Developments/Updates
Table 66. Aristo Pharmaceuticals Pvt Ltd Competitive Strengths & Weaknesses
Table 67. Novartis Basic Information, Manufacturing Base and Competitors
Table 68. Novartis Major Business
Table 69. Novartis Levoamlodipine Product and Services
Table 70. Novartis Levoamlodipine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Novartis Recent Developments/Updates
Table 72. Novartis Competitive Strengths & Weaknesses
Table 73. Pfizer Basic Information, Manufacturing Base and Competitors
Table 74. Pfizer Major Business
Table 75. Pfizer Levoamlodipine Product and Services
Table 76. Pfizer Levoamlodipine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Pfizer Recent Developments/Updates
Table 78. Pfizer Competitive Strengths & Weaknesses
Table 79. Lek Basic Information, Manufacturing Base and Competitors
Table 80. Lek Major Business
Table 81. Lek Levoamlodipine Product and Services
Table 82. Lek Levoamlodipine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Lek Recent Developments/Updates
Table 84. Lek Competitive Strengths & Weaknesses
Table 85. TEVA Basic Information, Manufacturing Base and Competitors
Table 86. TEVA Major Business
Table 87. TEVA Levoamlodipine Product and Services
Table 88. TEVA Levoamlodipine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. TEVA Recent Developments/Updates
Table 90. TEVA Competitive Strengths & Weaknesses
Table 91. Macleods Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 92. Macleods Pharmaceuticals Major Business
Table 93. Macleods Pharmaceuticals Levoamlodipine Product and Services
Table 94. Macleods Pharmaceuticals Levoamlodipine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Macleods Pharmaceuticals Recent Developments/Updates
Table 96. Macleods Pharmaceuticals Competitive Strengths & Weaknesses
Table 97. Caraco Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 98. Caraco Pharmaceutical Major Business
Table 99. Caraco Pharmaceutical Levoamlodipine Product and Services
Table 100. Caraco Pharmaceutical Levoamlodipine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Caraco Pharmaceutical Recent Developments/Updates
Table 102. Caraco Pharmaceutical Competitive Strengths & Weaknesses
Table 103. Sanis Health Basic Information, Manufacturing Base and Competitors
Table 104. Sanis Health Major Business
Table 105. Sanis Health Levoamlodipine Product and Services
Table 106. Sanis Health Levoamlodipine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Sanis Health Recent Developments/Updates
Table 108. Sanis Health Competitive Strengths & Weaknesses
Table 109. Jamp Pharma Basic Information, Manufacturing Base and Competitors
Table 110. Jamp Pharma Major Business
Table 111. Jamp Pharma Levoamlodipine Product and Services
Table 112. Jamp Pharma Levoamlodipine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Jamp Pharma Recent Developments/Updates
Table 114. Jamp Pharma Competitive Strengths & Weaknesses
Table 115. Accel Pharma Basic Information, Manufacturing Base and Competitors
Table 116. Accel Pharma Major Business
Table 117. Accel Pharma Levoamlodipine Product and Services
Table 118. Accel Pharma Levoamlodipine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Accel Pharma Recent Developments/Updates
Table 120. Accel Pharma Competitive Strengths & Weaknesses
Table 121. Jubilant Generics Basic Information, Manufacturing Base and Competitors
Table 122. Jubilant Generics Major Business
Table 123. Jubilant Generics Levoamlodipine Product and Services
Table 124. Jubilant Generics Levoamlodipine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Jubilant Generics Recent Developments/Updates
Table 126. Jubilant Generics Competitive Strengths & Weaknesses
Table 127. Angita Pharma Basic Information, Manufacturing Base and Competitors
Table 128. Angita Pharma Major Business
Table 129. Angita Pharma Levoamlodipine Product and Services
Table 130. Angita Pharma Levoamlodipine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Angita Pharma Recent Developments/Updates
Table 132. Angita Pharma Competitive Strengths & Weaknesses
Table 133. Florida DOH Central Pharmacy Basic Information, Manufacturing Base and Competitors
Table 134. Florida DOH Central Pharmacy Major Business
Table 135. Florida DOH Central Pharmacy Levoamlodipine Product and Services
Table 136. Florida DOH Central Pharmacy Levoamlodipine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Florida DOH Central Pharmacy Recent Developments/Updates
Table 138. Florida DOH Central Pharmacy Competitive Strengths & Weaknesses
Table 139. Chengdu Di'ao Pharmaceutical Group Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 140. Chengdu Di'ao Pharmaceutical Group Co., Ltd. Major Business
Table 141. Chengdu Di'ao Pharmaceutical Group Co., Ltd. Levoamlodipine Product and Services
Table 142. Chengdu Di'ao Pharmaceutical Group Co., Ltd. Levoamlodipine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Chengdu Di'ao Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 144. Yangzijiang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 145. Yangzijiang Pharmaceutical Major Business
Table 146. Yangzijiang Pharmaceutical Levoamlodipine Product and Services
Table 147. Yangzijiang Pharmaceutical Levoamlodipine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 148. Global Key Players of Levoamlodipine Upstream (Raw Materials)
Table 149. Levoamlodipine Typical Customers
Table 150. Levoamlodipine Typical Distributors
LIST OF FIGURES
Figure 1. Levoamlodipine Picture
Figure 2. World Levoamlodipine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Levoamlodipine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Levoamlodipine Production (2018-2029) & (K Units)
Figure 5. World Levoamlodipine Average Price (2018-2029) & (US$/Unit)
Figure 6. World Levoamlodipine Production Value Market Share by Region (2018-2029)
Figure 7. World Levoamlodipine Production Market Share by Region (2018-2029)
Figure 8. North America Levoamlodipine Production (2018-2029) & (K Units)
Figure 9. Europe Levoamlodipine Production (2018-2029) & (K Units)
Figure 10. China Levoamlodipine Production (2018-2029) & (K Units)
Figure 11. Japan Levoamlodipine Production (2018-2029) & (K Units)
Figure 12. Levoamlodipine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Levoamlodipine Consumption (2018-2029) & (K Units)
Figure 15. World Levoamlodipine Consumption Market Share by Region (2018-2029)
Figure 16. United States Levoamlodipine Consumption (2018-2029) & (K Units)
Figure 17. China Levoamlodipine Consumption (2018-2029) & (K Units)
Figure 18. Europe Levoamlodipine Consumption (2018-2029) & (K Units)
Figure 19. Japan Levoamlodipine Consumption (2018-2029) & (K Units)
Figure 20. South Korea Levoamlodipine Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Levoamlodipine Consumption (2018-2029) & (K Units)
Figure 22. India Levoamlodipine Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Levoamlodipine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Levoamlodipine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Levoamlodipine Markets in 2022
Figure 26. United States VS China: Levoamlodipine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Levoamlodipine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Levoamlodipine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Levoamlodipine Production Market Share 2022
Figure 30. China Based Manufacturers Levoamlodipine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Levoamlodipine Production Market Share 2022
Figure 32. World Levoamlodipine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Levoamlodipine Production Value Market Share by Type in 2022
Figure 34. Amlodipine Besylate Tablets
Figure 35. Amlodipine Mesylate Tablets
Figure 36. Amlodipine Maleate Tablets
Figure 37. World Levoamlodipine Production Market Share by Type (2018-2029)
Figure 38. World Levoamlodipine Production Value Market Share by Type (2018-2029)
Figure 39. World Levoamlodipine Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Levoamlodipine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Levoamlodipine Production Value Market Share by Application in 2022
Figure 42. Hypertension
Figure 43. Angina pectoris
Figure 44. World Levoamlodipine Production Market Share by Application (2018-2029)
Figure 45. World Levoamlodipine Production Value Market Share by Application (2018-2029)
Figure 46. World Levoamlodipine Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Levoamlodipine Industry Chain
Figure 48. Levoamlodipine Procurement Model
Figure 49. Levoamlodipine Sales Model
Figure 50. Levoamlodipine Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
Figure 1. Levoamlodipine Picture
Figure 2. World Levoamlodipine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Levoamlodipine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Levoamlodipine Production (2018-2029) & (K Units)
Figure 5. World Levoamlodipine Average Price (2018-2029) & (US$/Unit)
Figure 6. World Levoamlodipine Production Value Market Share by Region (2018-2029)
Figure 7. World Levoamlodipine Production Market Share by Region (2018-2029)
Figure 8. North America Levoamlodipine Production (2018-2029) & (K Units)
Figure 9. Europe Levoamlodipine Production (2018-2029) & (K Units)
Figure 10. China Levoamlodipine Production (2018-2029) & (K Units)
Figure 11. Japan Levoamlodipine Production (2018-2029) & (K Units)
Figure 12. Levoamlodipine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Levoamlodipine Consumption (2018-2029) & (K Units)
Figure 15. World Levoamlodipine Consumption Market Share by Region (2018-2029)
Figure 16. United States Levoamlodipine Consumption (2018-2029) & (K Units)
Figure 17. China Levoamlodipine Consumption (2018-2029) & (K Units)
Figure 18. Europe Levoamlodipine Consumption (2018-2029) & (K Units)
Figure 19. Japan Levoamlodipine Consumption (2018-2029) & (K Units)
Figure 20. South Korea Levoamlodipine Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Levoamlodipine Consumption (2018-2029) & (K Units)
Figure 22. India Levoamlodipine Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Levoamlodipine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Levoamlodipine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Levoamlodipine Markets in 2022
Figure 26. United States VS China: Levoamlodipine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Levoamlodipine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Levoamlodipine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Levoamlodipine Production Market Share 2022
Figure 30. China Based Manufacturers Levoamlodipine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Levoamlodipine Production Market Share 2022
Figure 32. World Levoamlodipine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Levoamlodipine Production Value Market Share by Type in 2022
Figure 34. Amlodipine Besylate Tablets
Figure 35. Amlodipine Mesylate Tablets
Figure 36. Amlodipine Maleate Tablets
Figure 37. World Levoamlodipine Production Market Share by Type (2018-2029)
Figure 38. World Levoamlodipine Production Value Market Share by Type (2018-2029)
Figure 39. World Levoamlodipine Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Levoamlodipine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Levoamlodipine Production Value Market Share by Application in 2022
Figure 42. Hypertension
Figure 43. Angina pectoris
Figure 44. World Levoamlodipine Production Market Share by Application (2018-2029)
Figure 45. World Levoamlodipine Production Value Market Share by Application (2018-2029)
Figure 46. World Levoamlodipine Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Levoamlodipine Industry Chain
Figure 48. Levoamlodipine Procurement Model
Figure 49. Levoamlodipine Sales Model
Figure 50. Levoamlodipine Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
